| Evaluation of Orthohepevirus C Infection as an Emerging Cause of Zoonotic Origin Disease (NCT05062967) | Maimónides Biomedical Research Institute of Córdoba | 2022-01-01 |
| ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment (NCT05414552) | University of Freiburg | 2021-06-01 |
| Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1 (NCT04618575) | West China Hospital | 2021-03-17 |
| Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 (NCT04846010) | All Natural Medicine Clinic, LLC | 2021-03-01 |
| Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019? (NCT04757272) | Zagazig University | 2020-05-01 |
| Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors. (NCT04595734) | Western Sydney Local Health District | 2020-01-07 |
| Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination (NCT03776760) | Kirby Institute | 2019-05-28 |
| HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I) (NCT03685708) | National Heart, Lung, and Blood Institute (NHLBI) | 2018-12-07 |
| An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection (NCT03692897) | Target PharmaSolutions, Inc. | 2018-10-11 |
| Crowdsourcing to Promote HBV and HCV Testing in China (NCT03482388) | University of North Carolina, Chapel Hill | 2018-05-09 |
| Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines (NCT03410953) | Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León | 2018-04-13 |
| Monitoring the IMmUological TOXicity of Drugs (NCT03480529) | Groupe Hospitalier Pitie-Salpetriere | 2018-03-01 |
| Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings (NCT03089983) | Yale University | 2017-08-21 |
| the Possible Effect of the Antiviral Inhibitors for Treatment of Hepatitis C Virus Infection in Cardiac Function (NCT03166943) | Assiut University | 2017-05-10 |
| Evaluation of Hepatic Fibrosis on Multiparametric MRI (NCT03085342) | Seoul National University Hospital | 2017-04-04 |
| A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR-TND Tablet(Tenofovir Disoproxil) With Viread Tablet(Tenofovir Disoproxil Fumarate) in Healthy Male Volunteers (NCT02920931) | Boryung Pharmaceutical Co., Ltd | 2016-02-01 |
| Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021) (NCT02613403) | Merck Sharp & Dohme LLC | 2015-12-10 |
| Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection (NCT03119025) | Russian Academy of Medical Sciences | 2015-05-01 |
| Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates (NCT02764671) | Shenzhen Kangtai Biological Products Co., LTD | 2015-05-01 |
| Empowering Immigrants in the Greater Boston Area to Connect to HBV Care (NCT02342821) | Massachusetts General Hospital | 2015-02-01 |
| Comparative Assessment of Utilization of Antiviral Therapies in Hepatitis C and Effectiveness of Daclatasvir-containing Regimens in Real-life Clinical Care in Europe (CMPASS-EU) (NCT02368522) | Bristol-Myers Squibb | 2014-12-01 |
| Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study (NCT04306939) | University of Pittsburgh | 2014-11-01 |
| The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical Trial (NCT03509688) | The First Hospital of Jilin University | 2014-11-01 |
| Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection (NCT02128217) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2014-05-30 |
| Comorbidities and Virologic Outcome Among Patients on Anti-retroviral Therapy in Rural Lesotho (NCT02126696) | Swiss Tropical & Public Health Institute | 2014-05-01 |
| TO Compare the Triple Drug Therapy and Dual Therapy . (NCT02075242) | Asan Medical Center | 2014-01-01 |
| Immune Cell Dysfunction in Severe Alcoholic Hepatitis (NCT02275195) | Mid and South Essex NHS Foundation Trust | 2013-11-01 |
| An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C (NCT01889433) | Biocad | 2013-07-10 |
| An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients (NCT02103439) | Biocad | 2013-06-06 |
| Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment (NCT01724723) | National Taiwan University Hospital | 2012-12-01 |
| Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma (NCT01641276) | Hospital Sirio-Libanes | 2012-04-01 |
| Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients (NCT01645033) | Yale University | 2012-04-01 |
| Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis C (NCT01740089) | Biocad | 2011-11-01 |
| Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV (NCT01443923) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-09-01 |
| Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment (NCT01395654) | National Taiwan University Hospital | 2011-07-01 |
| The Health Access and Recovery Peer Program (NCT01725815) | Emory University | 2011-06-01 |
| Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced Hepatotoxicity (NCT01456845) | All India Institute of Medical Sciences | 2010-08-01 |
| Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (NCT01434212) | The First Hospital of Jilin University | 2010-05-01 |
| Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention (NCT01142882) | National Development and Research Institutes, Inc. | 2010-02-01 |
| HCV Epidemiological Survey in China Rural Area (NCT04593355) | The First Hospital of Jilin University | 2009-12-01 |
| Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects (NCT00987337) | Pfizer | 2009-11-01 |
| Role of Cytokines in Hepatitis E Virus Infection During Pregnancy (NCT01062321) | Maulana Azad Medical College | 2009-08-01 |
| Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian Children (NCT01159925) | GlaxoSmithKline | 2009-07-01 |
| Effectiveness of Hepatitis A Virus Vaccination Among Homosexual Males at Risk for Hepatitis A Infection (NCT01102296) | National Taiwan University Hospital | 2009-06-01 |
| ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV (NCT00901524) | ANRS, Emerging Infectious Diseases | 2009-06-01 |
| Epidemiological Study in Children and Adolescents With Chronic Hepatitis B (NCT01163240) | Novartis Pharmaceuticals | 2009-06-01 |
| The Efficacy and Safety of Pioglitazone in Patients With Nonalcoholic Steatohepatitis (NCT01068444) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2009-04-01 |
| A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis B (NCT00815464) | Yu Medical Garden | 2009-03-01 |
| Analysis of Trends Over Time of Hepatitis Related Incidence in Panama (NCT01159951) | GlaxoSmithKline | 2009-01-01 |
| MRI to Measure Liver Fat Content (NCT00594412) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-12-20 |
| Anti-tuberculosis (TB) Drug Levels and Hepatotoxicity (NCT00929786) | All India Institute of Medical Sciences | 2007-11-01 |
| Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity (NCT00564642) | National Research Institute of Tuberculosis and Lung Disease, Iran | 2007-11-01 |
| Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients (NCT02108444) | Peking University | 2007-01-01 |
| Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease (NCT00679692) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2006-09-01 |
| Protein Biomarker in Hepatocellular Carcinoma (NCT00465842) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-06-20 |
| HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group. (NCT00147784) | Sorlandet Hospital HF | 2006-03-01 |
| VaxTeen Hepatitis B Vaccine Booster Study (NCT00144313) | Centers for Disease Control and Prevention | 2005-08-01 |
| HIV-HCV Coinfection: Impact of Immune Dysfunction (NCT00575315) | Virginia Commonwealth University | 2004-07-01 |
| S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis (NCT00108589) | US Department of Veterans Affairs | 2004-01-01 |
| Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis (NCT00076336) | Novartis Pharmaceuticals | 2003-12-01 |
| Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation (NCT00080236) | Conatus Pharmaceuticals Inc. | 2003-11-01 |
| Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH) (NCT00160407) | St. Louis University | 2003-10-01 |
| Efficacy of Silymarin for Acute Hepatitis (NCT00412763) | University of Maryland, Baltimore | 2003-07-01 |
| Treating Nonalcoholic Steatohepatitis (NASH) With Metformin (NCT00063232) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-06-01 |
| A Network & Dyad HIV Prevention Intervention for IDU's - 1 (NCT00218335) | Johns Hopkins Bloomberg School of Public Health | 2003-06-01 |
| Treating Nonalcoholic Steatohepatitis With Pioglitazone (NCT00062764) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-06-01 |
| Hepatitis C: Grading and Staging by MR (NCT00059397) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-04-01 |
| Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users (NCT00194480) | National Institute on Drug Abuse (NIDA) | 2003-04-01 |
| PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370) (NCT00039871) | Merck Sharp & Dohme LLC | 2002-05-01 |
| Lamivudine and Adefovir to Treat Chronic Hepatitis B (NCT00023309) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2001-08-01 |
| A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal. (NCT00287469) | U.S. Army Medical Research and Development Command | 2001-07-09 |
| Twinrix Pregnancy Registry (NCT03619590) | GlaxoSmithKline | 2001-05-18 |
| Collections of Blood and Stool Samples in Patients With Acute Hepatitis (NCT00001879) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-03-01 |
| Manhattan HIV/Hepatology Brain Bank (NCT00300209) | Icahn School of Medicine at Mount Sinai | 1998-09-01 |
| A Controlled Prospective Study of Transfusion-Associated Hepatitis (NCT00004848) | National Institutes of Health Clinical Center (CC) | 1981-07-01 |